Bect Medical brought a number of debut exhibits to the 5th CIIE, and the innovation ecology helped healthy China

SHANGHAI, Nov.
7, 2022 /PRNewswire/ -- On November 5, 2022, the 5th China International Import Expo (hereinafter referred to as the "CIIE") was grandly opened at the National Exhibition and Convention Center (Shanghai), and the global medical technology giant Bedi Medical went to the Expo three times, with the theme of "Committed to Innovation, Future Health", the 2022 premiere new product exhibition area, the life holographic rhythm exhibition hall two highlight exhibition areas, as well as digital intelligence medical, The three theme exhibition areas of digital patient education and smart hospital were unveiled, with an exhibition area of up to 600 square meters, bringing many world-leading innovative exhibits and solutions, comprehensively demonstrating the development concept of BIDI Medical driven by technological innovation and leading the future direction of the industry, practicing the determination and commitment
to take root in China, serve China, actively build a local innovation ecosystem, and promote the development of domestic medical technology innovation.

Many debuts gathered, and innovative exhibits attracted attention

The 5th CIIE is a major international exhibition, with high-quality enterprises from all over the world bringing a large number of "high-precision and cutting-edge" exhibits to participate in the exhibition
.
At this Expo, Beida Medical also handed over a brilliant scientific and technological innovation report card, and many of the debut products displayed in the 2022 debut new product exhibition area were eye-catching and received a lot of attention
.
These include the world's first single-use breast atherectomy needle with irrigation tube, the Asian premiere of the BD Liverty adjustable transjugular intrahepatic puncture device, and the four major Chinese premieres BD Viper LT System, LUTONIX 035 PTA drug balloon dilation catheter, Covera vascular stent TissuePatch can absorb a number of new products
, including polymer tissue sealing film.

In the "Life Holographic Rhythm Exhibition Hall" on site, Becta Medical created an immersive intraoperative and postoperative innovative product and solution scene through holographic technology, so that visitors could intuitively feel the improvement of postoperative life quality and clinical safety brought by innovative medical technology in the process of patients' head-to-toe experience, and comprehensively demonstrated the concept
of customer-centric and leading a healthy future.

In addition, the BD FACSDiscover S8 flow cytometry sorter, which was released as a warm-up at the site, can also be said to be one of the most important exhibits of
Becton Medical.
It is the world's first full-spectrum flow cytometry sorter
with image analysis.
By integrating spectral flow cytometry and morphological information, spectral analysis and real-time spatial morphological information can be integrated for the first time, expanding the dimension of cell research and unlocking new applications to help scientists make breakthrough discoveries
in less time.
As the inventor of flow cytometry technology, this new product is a heavyweight equipment launched by the Bioscience R&D team of Bidi Medical in the past ten years, the product innovatively uses 5G communication technology, at the same time, with the same bandwidth, processing massive information and real-time interaction, the speed is increased by more than 3 times, and the amount of information is increased by 6 times
。 This new equipment based on "three-in-one" technology will effectively help hospitals, universities, research institutes, CDCs, and biomedical innovation enterprises to build a comprehensively upgraded scientific research platform, build first-class disciplines, cultivate first-class talents, produce first-class results, solve more complex life science problems, make breakthrough discoveries and help research on public health topics, and is an epoch-making innovative product
in the field of life sciences.

Another eye-catching exhibit is the world's first FDA-approved drug-coated balloon - LUTONIX drug balloon dilation catheter, which has accumulated clinical practice data and use experience of more than 600,000 people around the world, and its low toxicity, low embolization rate and long-term efficacy have been verified by a large number of clinical practice data; From the perspective of the product itself, its unique coating patent technology can avoid drug loss and more effectively deliver drugs to target lesions, thereby reducing drug dosage and toxicity, improving patient efficacy and safety, and reducing surgical complications, thereby
benefiting patients.

In recent years, benefiting from the reform of the review system, a number of innovative products of the peripheral vascular business of BIDI Medical have been approved for marketing in China through rich and reliable overseas clinical data, and thanks to a clearer and more efficient review process, BIDI innovative products can be listed abroad to ensure that they enter the Chinese market as soon as possible, meet the clinical needs of Chinese patients and physicians, and provide unique clinical value
.

Deng Jianmin, Senior Vice President of Global and General Manager of Greater China, said, "With the support of the national policy to encourage innovation, Bita Medical will increase innovative research and development on some unsolved medical and scientific research needs, create innovative products that meet China's clinical and scientific research needs, and accelerate the landing of innovative products in China, so as to benefit Chinese patients and help the implementation of
the Healthy China strategy.
" 。 With the platform effect of openness, innovation, cooperation and win-win at the Expo, Becton Medical also looks forward to empowering each other with more partners, promoting the development of medical technology innovation, realizing health for all at an early date, and moving forward in the direction of building a community with a shared future for all mankind
.
"

During the Expo, Becton Medical also signed a number of cooperation agreements with hospital groups, procurement centers and other platforms and institutions to jointly promote the development of China's innovative medical technology and the improvement
of diagnosis and treatment level.
At the same time, Becton Medical also published the "Research Report on Value Evaluation and Practice Application of High-value Medical Consumables", which provides value-oriented decision-making evidence for consumables medical insurance and hospital access
.

Patient-centric and local innovation ecosystem

"Patient-centered" is the corporate value that Becton Medical has always emphasized, and scientific and technological innovation should solve clinical problems around patients and continuously meet diversified needs
.
To this end, Becton Medical has also made many attempts, such as innovating payment methods and cooperating with insurance companies to set up specific medical insurance programs; In the Hainan Boao Lecheng International Medical Tourism Pilot Zone, it took the lead in introducing advanced products to be launched in China, so that some patients can use them in advance; Use digital and intelligent means to make advanced products more accessible to patients and so on
.

At the same time, Bedi Medical has been adhering to the strategic concept of "in China, for China (rooted in China, serving China)", and gradually established a complete value chain in China, including from R&D, production, marketing to after-sales service
.
At present, a total of 8 companies have been invested in China, 3 local manufacturing plants, 6 training centers, 2 R&D centers, 1 customer service center, 2 customer experience centers and innovation centers have been established to serve more Chinese patients and medical workers and help promote the development of
China's medical industry.

Deng Jianmin, Senior Vice President of Global and General Manager of Greater China, said, "On the one hand, we have increased our efforts to cultivate local innovation, and established the "R&D dual-center strategy" with Shanghai as the innovation design center and multi-functional laboratory and Suzhou as the laboratory engineering center, based on the needs of the Chinese market, optimize product functions, accelerate product implementation, and better meet the needs of the local market while benefiting more patients; On the other hand, we strengthen local production, expand local production capacity, and promote the localization of products; Improve supply chain stability, resist external risks, improve response efficiency to customers, and ultimately better serve Chinese patients and care
.
"

Not only that, Bita Medical adheres to the patient-centered, rooted in China's local market environment, actively seeks local enterprises, clinical experts, government agencies and other partners in industry, academia, research, medicine, government and other industries, creates an integrated innovation ecosystem, calls on all parties to use their respective advantages to solve the unmet needs of local medical care, benefit patients, facilitate medical care, optimize hospital management, etc.
, and continue to create value
for doctors and patients.
At the same time, we will continue to promote the sinking of medical products and services, continue to improve affordability, reach more patients, and achieve cost reduction, efficiency improvement and comprehensive upgrading
of the medical industry value chain.